{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:52:18Z","timestamp":1788367938515,"version":"build-2803163510"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Neurotoxic phenomena are among the most common side effects of cytotoxic agents. The development of chemotherapy-induced polyneuropathy (CIPN) is a well-recognized adverse reaction in the peripheral nervous system, while changes of cognitive functions (post-chemotherapy cognitive impairment (PCCI)) are more diffuse and have only recently drawn scientific interest. PCCI in patients most often displays as short-term memory loss, reduced multitasking ability or deficits in language. Not least, due to a lack of preclinical human model systems, the underlying molecular mechanisms are poorly understood, and treatments are missing. We thus investigated whether induced pluripotent stem cell (iPSC)-derived brain organoids can serve as a human model system for the study of chemotherapy induced central nervous system toxicity. We robustly generated mature brain organoids from iPSC-derived neuronal precursor cells (NPC), which showed a typical composition with 1) dividing NPCs forming ventricle like structures 2) matured neurons and 3) supporting glial cells closer to the surface. Furthermore, upon stimulation the brain organoids showed functional signaling. When exposed to increasing concentrations of paclitaxel, a frequently used chemotherapy drug, we observed time dependent neurotoxicity with an EC50 of 153\u00a0nM, comparable to a published murine model system. Histological analysis after paclitaxel exposure demonstrated dose dependent apoptosis induction and reduced proliferation in the organoids with further Western blot analyses indicating the degradation of neuronal calcium sensor one protein (NCS-1) and activation of Caspase-3. We could also provide evidence that paclitaxel treatment negatively affects the pool of neuronal and astrocyte precursor cells as well as mature neurons. In summary our data suggests that human iPSC derived brain organoids are a promising preclinical model system to investigate molecular mechanisms underlying PCCI and to develop novel prevention and treatment strategies.<\/jats:p>","DOI":"10.3389\/fmolb.2022.1006497","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T11:01:43Z","timestamp":1663239703000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Induced pluripotent stem cell-derived brain organoids as potential human model system for chemotherapy induced CNS toxicity"],"prefix":"10.3389","volume":"9","author":[{"given":"Sophie","family":"Scholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Saulich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Boehmerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Huehnchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrc2073","article-title":"Candidate mechanisms for chemotherapy-induced cognitive changes","volume":"7","author":"Ahles","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nmeth.1896","article-title":"Omero: Flexible, model-driven data management for experimental biology","volume":"9","author":"Allan","year":"2012","journal-title":"Nat. Methods"},{"key":"B3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00115-014-4126-3","article-title":"Chemotherapy-induced neuropathy","volume":"86","author":"Boehmerle","year":"2015","journal-title":"Nervenarzt"},{"key":"B4","doi-asserted-by":"publisher","first-page":"18356","DOI":"10.1073\/pnas.0607240103","article-title":"Paclitaxel induces calcium oscillations via an inositol 1, 4, 5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism","volume":"103","author":"Boehmerle","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11103","DOI":"10.1073\/pnas.0701546104","article-title":"Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation","volume":"104","author":"Boehmerle","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.tips.2005.11.009","article-title":"Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs","volume":"27","author":"Breedveld","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/stem.3237","article-title":"Replicates in stem cell models-How complicated","volume":"38","author":"Chan","year":"2020","journal-title":"Stem Cells"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cell.2018.10.049","article-title":"Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment","volume":"176","author":"Gibson","year":"2019","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1185","DOI":"10.1038\/tp.2017.149","article-title":"A novel preventive therapy for paclitaxel-induced cognitive deficits: Preclinical evidence from C57bl\/6 mice","volume":"7","author":"Huehnchen","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e154395","DOI":"10.1172\/jci.insight.154395","article-title":"Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy","volume":"7","author":"Huehnchen","year":"2022","journal-title":"JCI Insight"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neuron.2012.01.024","article-title":"Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis","volume":"74","author":"Kang","year":"2012","journal-title":"Neuron"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e46635","DOI":"10.15252\/embr.201846635","article-title":"Sequentially acting SOX proteins orchestrate astrocyte- and oligodendrocyte-specific gene expression","volume":"19","author":"Klum","year":"2018","journal-title":"EMBO Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuro.2013.05.008","article-title":"Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: Implications for chemotherapy-induced peripheral neuropathy","volume":"37","author":"LaPointe","year":"2013","journal-title":"Neurotoxicology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.neuron.2007.04.019","article-title":"Timing is everything: Making neurons versus glia in the developing cortex","volume":"54","author":"Miller","year":"2007","journal-title":"Neuron"},{"key":"B16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1188\/08.ONF.916-920","article-title":"Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment","volume":"35","author":"Myers","year":"2008","journal-title":"Oncol. Nurs. Forum"},{"key":"B17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/s0168-0102(99)00074-7","article-title":"Morphological evidence of the inhibitory effect of taxol on the fast axonal transport","volume":"35","author":"Nakata","year":"1999","journal-title":"Neurosci. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e12075","DOI":"10.15252\/emmm.202012075","article-title":"Cellular mechanisms and treatments for chemobrain: Insight from aging and neurodegenerative diseases","volume":"12","author":"Nguyen","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-021-00463-2","article-title":"Pharmacological rescue of cognitive function in a mouse model of chemobrain","volume":"16","author":"Nguyen","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"B20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diff.2021.03.001","article-title":"Effects of taxol on neuronal differentiation of postnatal neural stem cells cultured from mouse subventricular zone","volume":"119","author":"Park","year":"2021","journal-title":"Differentiation."},{"key":"B22","doi-asserted-by":"publisher","first-page":"895284","DOI":"10.3389\/fcell.2022.895284","article-title":"3-Dimensional model to study apoptosis induction of activated natural killer cells conditioned medium using patient-derived colorectal cancer organoids","volume":"10","author":"Parseh","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","article-title":"Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture","volume":"12","author":"Pasca","year":"2015","journal-title":"Nat. Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1093\/bioinformatics\/btab160","article-title":"FRC-QE: A robust and comparable 3D microscopy image quality metric for cleared organoids","volume":"37","author":"Preusser","year":"2021","journal-title":"Bioinformatics"},{"key":"B25","volume-title":"R: A language and environment for statistical computing","year":"2021"},{"key":"B26","doi-asserted-by":"publisher","first-page":"715054","DOI":"10.3389\/fnmol.2021.715054","article-title":"Cell-type-specific high throughput toxicity testing in human midbrain organoids","volume":"14","author":"Renner","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.15252\/embj.201694700","article-title":"Self-organized developmental patterning and differentiation in cerebral organoids","volume":"36","author":"Renner","year":"2017","journal-title":"EMBO J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-response analysis using R","volume":"10","author":"Ritz","year":"2015","journal-title":"PLoS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"605255","DOI":"10.3389\/fncel.2021.605255","article-title":"Organoid models of glioblastoma and their role in drug discovery","volume":"15","author":"Rybin","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"105391","DOI":"10.1016\/j.nbd.2021.105391","article-title":"Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC) -derived sensory neurons","volume":"155","author":"Schinke","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"B32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.critrevonc.2007.06.001","article-title":"Cognitive function after chemotherapy in adults with solid tumours","volume":"63","author":"Vardy","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11682-017-9728-5","article-title":"A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer","volume":"13","author":"Vardy","year":"2019","journal-title":"Brain Imaging Behav."},{"key":"B34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13041-015-0115-0","article-title":"Sox9 is critical for suppression of neurogenesis but not initiation of gliogenesis in the cerebellum","volume":"8","author":"Vong","year":"2015","journal-title":"Mol. Brain"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant graphics for data analysis","author":"Wickham","year":"2016"},{"key":"B36","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.2147\/OTT.S237431","article-title":"The anti-tumor effect of nab-paclitaxel proven by patient-derived organoids","volume":"13","author":"Xiao","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.stemcr.2021.06.011","article-title":"Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology","volume":"16","author":"Xu","year":"2021","journal-title":"Stem Cell Rep."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1006497\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T11:01:46Z","timestamp":1663239706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1006497\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":37,"alternative-id":["10.3389\/fmolb.2022.1006497"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.1006497","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"article-number":"1006497"}}